Publisher
Springer Science and Business Media LLC
Reference89 articles.
1. Bahl K, Senn JJ, Yuzhakov O, Bulychev A, Brito LA, Hassett KJ, Laska ME, Smith M, Almarsson Ö, Thompson J et al (2017) Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against h10n8 and h7n9 influenza viruses. Mol Ther 25(6):1316–1327
2. Bai Y, Liu D, He Q, Liu J, Mao Q, Liang Z (2023) Research progress on circular RNA vaccines. Front Immunol 13:1091797
3. Bansal S, Perincheri S, Fleming T, Poulson C, Tiffany B, Bremner RM, Mohanakumar T (2021) Cutting edge: circulating exosomes with covid spike protein are induced by bnt162b2 (pfizer-biontech) vaccination prior to development of antibodies: a novel mechanism for immune activation by mRNA vaccines. J Immunol 207(10):2405–2410
4. Baradaran A, Malek A, Moazzen N, Shaye ZA (2020) Covid-19 associated multisystem inflammatory syndrome: a systematic review and meta-analysis. Iran J Allergy Asthma Immunol
5. Bio Space. Harrisvaccines becomes first in the nation to receive united states department of agriculture (usda) conditional license for pedv vaccine. https://www.biospace.com/article/releases/harrisvaccines-becomes-first-in-the-nation-to-receive-united-states-department-of-agriculture-usda-conditional-license-for-pedv-vaccine-/?s=104, 2014. last accessed July 13, 2024